资讯
Doing business in the “Art of the Deal” age is tricky, but retail and fashion companies are zeroing in on an approach.
Verastem (VSTM) announced positive updated safety and efficacy results from the RAMP 205 Phase 1/2 trial evaluating avutometinib plus defactinib in combination with gemcitabine and Nab-paclitaxel in ...
30 分钟
Investor's Business Daily on MSNDow Jones Futures: Stock Market Resilient Amid Trump Tariff Threats; Nvidia Earnings Due ...Dow Jones futures will open Sunday evening, along with S&P 500 futures and Nasdaq futures. Nvidia and Fed inflation data headline the coming week, with investors spending the holiday weekend looking ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果